Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
Deloitte
US Department of Justice
Accenture
Teva
Chinese Patent Office
Cipla
Julphar

Generated: June 20, 2018

DrugPatentWatch Database Preview

NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Neomycin Sulfate-triamcinolone Acetonide patents expire, and when can generic versions of Neomycin Sulfate-triamcinolone Acetonide launch?

Neomycin Sulfate-triamcinolone Acetonide is a drug marketed by Fougera and Pharmaderm and is included in four NDAs.

The generic ingredient in NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
Drug patent expirations by year for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE

US Patents and Regulatory Information for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide CREAM;TOPICAL 062600-001 Jul 21, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmaderm NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide OINTMENT;TOPICAL 062607-001 May 23, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmaderm NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide CREAM;TOPICAL 062595-001 Jul 21, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fougera NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide OINTMENT;TOPICAL 062608-001 May 23, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Moodys
Accenture
Dow
Chinese Patent Office
Chubb
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.